---
figid: PMC7187988__nihms-1576642-f0002
figlink: pmc/articles/PMC7187988/figure/F2/
number: F2
caption: Activation of the seven transmembrane β-adrenergic receptors (β-AR) on adipocytes
  by norepinephrine (NE), leads to Gs-dependent activation of adenylyl cyclase (AC)
  to increase intracellular levels of cyclic-AMP (cAMP). cAMP activates protein kinase
  A (PKA) to phosphorylate (P) PLIN1, which release ABHD5 to fully activate PNPLA2
  TAG hydrolase activity and release a fatty acid (FA). PKA also phosphorylates HSL
  to promote its translocation to PLIN1 and increase its DAG hydrolase activity to
  release a FA and produce MAG. MAG is hydrolyzed by MGL to release a final FA and
  glycerol. Lipolysis can also be stimulated by natriuretic peptide (NP) which signals
  through the NP receptor-A (NPR-A) to increase guanylyl cyclase (GC)/cyclic-GMP (cGMP)
  and activation of protein kinase G (PKG). PKG can also phosphorylate HSL and PLIN1.
  Insulin, the main anti-lipolytic hormone (red lines), signals through the insulin
  receptor (IR) and insulin receptor substrate 1 and 2 (IRS1/2) to increase activity
  of phosphoinositide 3-kinase (PI3K) and levels of PIP3. PIP3 activates the kinase
  AKT, which through currently unknown mechanisms (?), activates phosphodiesterase
  3B (PDE3B) to hydrolyze cAMP to AMP. ABHD15, an AKT phosphorylation substrate, is
  required for the anti-lipolytic action of insulin and can bind to and stabilize
  PDE3B. Dotted line indicates movement of proteins, while the dashed red line notes
  currently unclear pathway of regulation.
pmcid: PMC7187988
papertitle: 'Adipocyte Lipolysis: from molecular mechanisms of regulation to disease
  and therapeutics..'
reftext: Alexander Yang, et al. Biochem J. ;477(5):985-1008.
pmc_ranked_result_index: '115834'
pathway_score: 0.9749967
filename: nihms-1576642-f0002.jpg
figtitle: Hormonal control of adipocyte lipolysis
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7187988__nihms-1576642-f0002.html
  '@type': Dataset
  description: Activation of the seven transmembrane β-adrenergic receptors (β-AR)
    on adipocytes by norepinephrine (NE), leads to Gs-dependent activation of adenylyl
    cyclase (AC) to increase intracellular levels of cyclic-AMP (cAMP). cAMP activates
    protein kinase A (PKA) to phosphorylate (P) PLIN1, which release ABHD5 to fully
    activate PNPLA2 TAG hydrolase activity and release a fatty acid (FA). PKA also
    phosphorylates HSL to promote its translocation to PLIN1 and increase its DAG
    hydrolase activity to release a FA and produce MAG. MAG is hydrolyzed by MGL to
    release a final FA and glycerol. Lipolysis can also be stimulated by natriuretic
    peptide (NP) which signals through the NP receptor-A (NPR-A) to increase guanylyl
    cyclase (GC)/cyclic-GMP (cGMP) and activation of protein kinase G (PKG). PKG can
    also phosphorylate HSL and PLIN1. Insulin, the main anti-lipolytic hormone (red
    lines), signals through the insulin receptor (IR) and insulin receptor substrate
    1 and 2 (IRS1/2) to increase activity of phosphoinositide 3-kinase (PI3K) and
    levels of PIP3. PIP3 activates the kinase AKT, which through currently unknown
    mechanisms (?), activates phosphodiesterase 3B (PDE3B) to hydrolyze cAMP to AMP.
    ABHD15, an AKT phosphorylation substrate, is required for the anti-lipolytic action
    of insulin and can bind to and stabilize PDE3B. Dotted line indicates movement
    of proteins, while the dashed red line notes currently unclear pathway of regulation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS2
  - IRS1
  - ADCY2
  - ADCY3
  - ADCY5
  - ADCY6
  - ADCY8
  - ADCY9
  - ADCY10
  - ADCY4
  - ADCY1
  - ADCY7
  - PLP2
  - NPR1
  - GC
  - AKT2
  - AKT3
  - AKT1
  - MFAP1
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - PDE3B
  - PRKG1
  - LIPE
  - FAP
  - ABHD5
  - PLIN1
  - DAG1
  - PNPLA2
  - MAG
  - MGLL
  - ATP
  - CGMP
  - TAG
  - glycerol
genes:
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: NPR-A
  symbol: NPRA
  source: hgnc_prev_symbol
  hgnc_symbol: NPR1
  entrez: '4881'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: АМР
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PDE3B
  symbol: PDE3B
  source: hgnc_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: HSL
  symbol: HSL
  source: hgnc_alias_symbol
  hgnc_symbol: LIPE
  entrez: '3991'
- word: FAP
  symbol: FAP
  source: hgnc_symbol
  hgnc_symbol: FAP
  entrez: '2191'
- word: ABHD5
  symbol: ABHD5
  source: hgnc_symbol
  hgnc_symbol: ABHD5
  entrez: '51099'
- word: PLIN1
  symbol: PLIN1
  source: hgnc_symbol
  hgnc_symbol: PLIN1
  entrez: '5346'
- word: HSL
  symbol: HSL
  source: hgnc_alias_symbol
  hgnc_symbol: LIPE
  entrez: '3991'
- word: DAĞ
  symbol: DAG
  source: hgnc_alias_symbol
  hgnc_symbol: DAG1
  entrez: '1605'
- word: PNPLA2
  symbol: PNPLA2
  source: hgnc_symbol
  hgnc_symbol: PNPLA2
  entrez: '57104'
- word: MAG-
  symbol: MAG
  source: hgnc_symbol
  hgnc_symbol: MAG
  entrez: '4099'
- word: MGL
  symbol: MGL
  source: hgnc_alias_symbol
  hgnc_symbol: MGLL
  entrez: '11343'
- word: ABHD5
  symbol: ABHD5
  source: hgnc_symbol
  hgnc_symbol: ABHD5
  entrez: '51099'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: CGMP
  source: MESH
  identifier: C016276
- word: TAG
  source: MESH
  identifier: C069631
- word: glycerol
  source: MESH
  identifier: D005990
diseases: []
figid_alias: PMC7187988__F2
redirect_from: /figures/PMC7187988__F2
figtype: Figure
---
